期刊文献+

地塞米松对肝癌细胞聚集^(18)F-FDG能力的影响

Effect of dexamethasone on the ^(18)F-FDG uptake capacity of hepatic carcinoma cells
下载PDF
导出
摘要 目的探讨地塞米松对肝癌细胞聚集18F-FDG能力的影响。方法根据地塞米松浓度将肝癌细胞HepG2和正常肝细胞L02分为0、10-8、10-7、10-6、10-5、10-4mol/L浓度处理组,每组均各设平行孔,对各组HepG2细胞和L02细胞预处理2、4、6、8、12、24 h,然后向各组加入1μCi18F-FDG孵育1 h,应用计数仪检测各组细胞的放射性计数。结果对HepG2细胞,当地塞米松浓度为10-8、10-7mol/L时,放射性计数减小(P<0.05),当地塞米松浓度为10-5、10-4mol/L时,放射性计数增高(P<0.05)。对L02细胞,当地塞米松浓度为10-8、10-7、10-6mol/L时,放射性计数减小(P<0.05),当地塞米松浓度为10-4mol/L时,放射性计数增高(P<0.05)。每组HepG2细胞18F-FDG放射性计数均高于L02细胞(P<0.05),且经地塞米松处理后,两种细胞放射性计数差值增大(P<0.05)。结论地塞米松对肝脏细胞聚集18F-FDG存在双向调节作用,适量浓度可以扩大肝癌细胞与正常肝细胞摄取18F-FDG的差异。 Objective To enhance the 18 F-FDG uptake capacity of hepatic carcinoma cells .Methods Hepatic carcinoma cell HepG2 and normal hepatic cell L02 were incubated for 2 h, 4 h, 6 h, 8 h, 12 h and 24 h with the dexam-ethasone of 10-8 mol/L,10-7 mol/L,10-6 mol/L,10-5 mol/L or 10-4 mol/L.The control group was treated without dexa -methasone.After that, 1 μCi 18 F -FDG was added for incubation into each group for 1 h, and the radioactivity counts were assessed subsequently.Results Dexamethasone significantly inhibited uptake capacity of the 18 F -FDG in HepG2 with the concentrations of 10-8 mol /L and 10-7 mol /L; promoted it with concentrations of 10-5 mol/L and 10-4 mol/L;and had no effect on it with the concentration of 10-6 mol/L (P &lt;0.05).Meanwhile, Dexamethasone significantly inhibi -ted uptake capacity of the 18 F -FDG in L02 with the concentrations of 10-8 mol/L, 10-7 mol/L and 10-6 mol/L; promo-ted it with concentrations of 10-4 mol /L; and had no effect on it with the concentration of 10-5 mol/L (P &lt;0.05).The 18 F -FDG uptake capacity of HepG2 was significantly higher than L02, and the difference was significantly enlarged by pre -treatment by dexamethasone (P &lt;0.05).Conclusion Dexamethasone has biphasic effect on the 18 F -FDG uptake capacity of hepatocytes.The appropriate concentration of dexamethasone can enlarge the 18 F -FDG uptake difference be-tween HepG2 and L02.
出处 《广东医学》 CAS 北大核心 2015年第3期333-335,共3页 Guangdong Medical Journal
基金 广东省自然科学基金资助项目(编号:S2012010009273)
关键词 地塞米松 肝细胞 HEPG2 L02 ^18F—FDG 葡萄糖8 dexamethasone hepatocytes HepG2 L02 ^18 F - FDG glucose
  • 相关文献

参考文献8

  • 1王丹萍,邵明玮,宋素彩,汪丽娟,栗夏连.地塞米松影响肝细胞糖代谢机制及吡格列酮干预作用的研究[J].中国糖尿病杂志,2013,21(3):279-282. 被引量:2
  • 2BAQUE S, ROCA A, GUINOVART J J, et al. Direct activating effects of dexamethasone on glycogen metabolizing enzymes in pri- mary cultured rat hepatocytes [ J]. Eur J Biochem, 1996, 236 (3) : 772 - 777.
  • 3ZHENG X F, LIU L, ZHOU J, et al. Biphasic effects of dexame- thasone on glycogen metabolism in primary cultured rat hepatocytes [J]. J Endocrinol Invest, 2009, 32(9) : 756 -758.
  • 4CODERRE L, VALLEGA G A, PILCH P F, et al. In vivo effects of dexamethasone and sucrose on glucose transport (GLUT -4 ) protein tissue distribution[ J. Am J Physiol, 1996, 271 (4 Pt 1 ) : E643 - E648.
  • 5DICH J, VIND C, GRUNNET N. Long - term culture of hepato- eytes: effect of hormones on enzyme activities and metabolic capa- city[J]. Hepatology, 1988, 8(1): 39-45.
  • 6FERNANDEZ MEJIA C, DAVIDSON M B. Regulation of glueoki- nase and proinsulin gene expression and insulin secretion in RIN - rnSF cells by dexamethasone, retinoic acid, and thyroid hormone [J]. Endocrinology, 1992, 130(3): 1660-1668.
  • 7PAGLIASSOTTI M J, WEI Y, BIZEAU M E. Glucose - 6 - phos- phatase activity is not suppressed but the mRNA level is increased by a sucrose -enriched meal in rats[J]. J Nutr, 2003, 133 (1) : 32 -37.
  • 8VOICE M W, WEBSTER A P, BURCHELL A. The in vivo regu- lation of liver and kidney glucose - 6 - phosphatase by dexametha- sone[J]. Horm Metab Res, 1997, 29(3) : 97 -100.

二级参考文献6

  • 1刘晓倩,巫冠中,皋聪,张文平,马莹,苏欣.磺酰脲类化合物G004体内外糖代谢的实验研究[J].中国新药杂志,2007,16(19):1581-1584. 被引量:7
  • 2Ferr6 P. The biology of peroxisone proliferator-activated recep- tors., relationship with lipid metabolism and insulin sensitity. Diabetes, 2004,53 : S43-S50.
  • 3Yuan L, Ziegler R, Hamann. Inhabition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepa- toeytes. Chin Med J, 2002,115 : 1843-1848.
  • 4Nedumaran B, Hong S, Xie YB, et al DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and nega- tively regulates the gluconeogenic enzyme gene expression. J Biol Chem,2009, 284:27511-27523.
  • 5Kim GS, Lee GY,Nedumaran B,ct al. The orphan nuclear re- ceptor DAX-1 acts as a novel transcriptional corepressor of PPAR. Biochem Biophys Res Commun, 2008,370 : 264-268.
  • 6Matthews L, Berry A, Tersigni M, et al. Thiazolidinediones are partial agonists for zhe glucocorticoid receptor. Endocrinology, 2009.150.75-86.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部